News summary

Perceptive Discovery Launches Astatine-211 Study Capabilities in the US and UK

Source: PR Newswire • Published: 16 Oct 2026, 10:04

Summarized by Masters of Longevity from PR Newswire.

Announcement that infrastructure and expertise for At-211 radiopharmaceutical development are now available across US and UK sites through a provider collaboration.

Perceptive Discovery Launches Astatine-211 Study Capabilities in the US and UK
Key Takeaways
  • Perceptive Discovery installed and validated an Atley C100 module at Queen Mary University of London for At-211 purification.
  • A second Atley C100 module will be installed at Perceptive Discovery's Needham, Massachusetts facility to expand US capabilities.
  • Perceptive Discovery will offer integrated At-211 radiochemistry with imaging, biodistribution, dosimetry, and translational development services.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.